Breast cancer
Breast cancer is one of the most common malignant tumors in women, with an incidence rate of 7-10% of all malignant tumors in the body, second only to uterine cancer in women, and has become a major cause of threat to women's health. Its onset is often related to genetics, and the incidence rate is higher in women between the ages of 40 and 60, before and after menopause. It is one of the most common malignant tumors that usually occurs in breast glandular epithelial tissue, seriously affecting women's physical and mental health and even endangering their lives. Breast cancer in men is rare, with only about 1-2% of breast patients being male.
-
Site of disease:
breast
-
Infectious :
Not contagious
-
Frequent population:
Women aged 45-55, late menopause, over...
-
Related symptoms:
Breast lumps
Distant metastasis of breast cancer
A palpable lump deep in the areola
Swelling of axillary lymph nodes
A peanut-sized lump on the lateral edge of the pectoralis major
-
Concurrent disease:
Related Drugs
Gemcitabine Hydrochloride
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.
Gemcitabine Hydrochloride
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Lianyungang JARI Pharmaceutical Co., Ltd.
Fluorouracil
Indication: It is clinically used for colon cancer, rectal cancer, gastric cancer, breast cancer, ovarian cancer, choriocarcinoma, malignant hydatidiform mole, head and neck squamous cell carcinoma, skin cancer, liver cancer, bladder cancer, etc.
Manufacturer:
Nantong Jinghua Pharmaceutical Co., Ltd.
Fluorouracil
Indication: It is clinically used for colon cancer, rectal cancer, gastric cancer, breast cancer, ovarian cancer, choriocarcinoma, malignant hydatidiform mole, head and neck squamous cell carcinoma, skin cancer, liver cancer, bladder cancer, etc.
Manufacturer:
Bei Jing Scrianen Pharmaceutical Co., Ltd.
Fluorouracil
Indication: It is clinically used for colon cancer, rectal cancer, gastric cancer, breast cancer, ovarian cancer, choriocarcinoma, malignant hydatidiform mole, head and neck squamous cell carcinoma, skin cancer, liver cancer, bladder cancer, etc.
Fluorouracil
Indication: It is clinically used for colon cancer, rectal cancer, gastric cancer, breast cancer, ovarian cancer, choriocarcinoma, malignant hydatidiform mole, head and neck squamous cell carcinoma, skin cancer, liver cancer, bladder cancer, etc.
Manufacturer:
Shanghai Xudong Haipu Nantong Pharmaceutical Co., Ltd.
Fluorouracil Tablets
Indication: It is the main chemotherapy drug for malignant hydatidiform mole and choriocarcinoma. It is also used for adjuvant chemotherapy and palliative treatment of breast cancer, digestive tract tumors (including primary and metastatic liver cancer and pancreatic cancer), ovarian cancer and primary bronchial lung cancer.
Manufacturer:
Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.
Fluorouracil Tablets
Indication: It is the main chemotherapy drug for malignant hydatidiform mole and choriocarcinoma. It is also used for adjuvant chemotherapy and palliative treatment of breast cancer, digestive tract tumors (including primary and metastatic liver cancer and pancreatic cancer), ovarian cancer and primary bronchial lung cancer.
Manufacturer:
Hainan General Alliance Pharmaceutical Co., Ltd.
Fluorouracil Tablets
Indication: It is the main chemotherapy drug for malignant hydatidiform mole and choriocarcinoma. It is also used for adjuvant chemotherapy and palliative treatment of breast cancer, digestive tract tumors (including primary and metastatic liver cancer and pancreatic cancer), ovarian cancer and primary bronchial lung cancer.
Manufacturer:
GRAND PHARMACEUTICAL(China) Co., Ltd.
Fluorouracil Tablets
Indication: It is the main chemotherapy drug for malignant hydatidiform mole and choriocarcinoma. It is also used for adjuvant chemotherapy and palliative treatment of breast cancer, digestive tract tumors (including primary and metastatic liver cancer and pancreatic cancer), ovarian cancer and primary bronchial lung cancer.
Manufacturer:
Xiuzheng Pharmaceutical Group Co., Ltd.